SB2020032001 - Improper access control in Insulet Omnipod Insulin Management System

CSH
CYBERSECURITY HELP
Sign In REGISTER

Main Vulnerability Database SB2020032001

SB2020032001 - Improper access control in Insulet Omnipod Insulin Management System

Published: March 20, 2020

Security Bulletin ID SB2020032001
CSH Severity
Low
Patch available
NO
Number of vulnerabilities 1
Exploitation vector Local access
Highest impact Data manipulation

Breakdown by Severity

Low 100%
  • Low
  • Medium
  • High
  • Critical

Description

This security bulletin contains information about 1 vulnerability.


1) Improper access control (CVE-ID: CVE-2020-10597)

CWE-ID: CWE-284 - Improper Access Control

CVSSv4: 7 [CVSS:4.0/AV:L/AC:L/AT:N/PR:N/UI:N/VC:L/VI:H/VA:L/SC:N/SI:N/SA:N]


The vulnerability allows a local attacker to gain unauthorized access to otherwise restricted functionality.

The vulnerability exists due to improper access restrictions in the wireless RF communication protocol. A local attacker with access to one of the affected insulin pump models can bypass implemented security restrictions and modify and/or intercept data.

The vulnerability can also allow attackers to change pump settings and control insulin delivery.

This vulnerability affects the following versions of the Omnipod Insulin Management System:

  • Product ID/Reorder number: 19191 and 40160
  • UDI/Model/NDC number: ZXP425 (10-Pack) and ZXR425 (10-Pack Canada)

    • Remediation

    Cybersecurity Help is not aware of any official remediation provided by the vendor.

    References